Topline data from pivotal Phase 3 TANDEM trial now expected in 4Q 2024 due to faster than expected enrollment – – On-track to report topline data from pivotal Phase 3 BROADWAY trial in 4Q 2024 – – ...
A team of Rice University bioengineers has developed a mathematical model that clarifies why interleukin-12 (IL-12)—a potent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback